{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:27:53Z","timestamp":1786973273303,"version":"build-2736575974"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"52","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,27]]},"DOI":"10.18632\/oncotarget.13040","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T17:54:26Z","timestamp":1478195666000},"page":"85861-85875","source":"Crossref","is-referenced-by-count":37,"title":["P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors"],"prefix":"10.18632","volume":"7","author":[{"given":"Joanna","family":"Kopecka","sequence":"first","affiliation":[{"name":"Department of Oncology, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Rankin","sequence":"additional","affiliation":[{"name":"Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Nathan, Queensland, 4111, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris C.","family":"Salaroglio","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Ann","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Nathan, Queensland, 4111, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Riganti","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-94-007-7359-2_2","article-title":"Physiological functions of the alpha class of carbonic anhydrases","volume":"75","author":"Frost","year":"2014","journal-title":"Subcell Biochem"},{"key":"2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9440(10)64762-1","article-title":"Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors","volume":"156","author":"Rajaniemi","year":"2000","journal-title":"Am J Pathol"},{"key":"3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2559.2006.02523.x","article-title":"Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours","volume":"49","author":"Parkkila","year":"2006","journal-title":"Histopathology"},{"key":"4","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1021\/ac101981t","article-title":"Immunoaffinity enrichment and liquid chromatography-selected reaction monitoring mass spectrometry for quantitation of carbonic anhydrase 12 in cultured renal carcinoma cells","volume":"82","author":"Hincapie","year":"2010","journal-title":"Anal Chem"},{"key":"5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013)","volume":"23","author":"De Simone","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ijc.29172","article-title":"A three-gene panel that distinguishes benign from malignant thyroid nodules","volume":"136","author":"Hui.","year":"2015","journal-title":"Int J Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"e33952","DOI":"10.1371\/journal.pone.0033952","article-title":"CAXII is a sero-diagnostic marker for lung cancer","volume":"7","author":"Sato","year":"2012","journal-title":"Plos ONE"},{"key":"8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1215\/15228517-2007-065","article-title":"Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas","volume":"10","author":"Parkkila","year":"2008","journal-title":"Neuro Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.oraloncology.2011.11.015","article-title":"Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis","volume":"48","author":"Yang","year":"2012","journal-title":"Oral Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7150\/jca.11269","article-title":"Carbonic anhydrase XII as an independent prognostic factor in advanced esophageal squamous cell carcinoma","volume":"6","author":"Otsuji","year":"2015","journal-title":"J Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Pouyss\u00e9gur","year":"2009","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors","volume":"54","author":"Poulsen","year":"2011","journal-title":"J Med Chem"},{"key":"13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/002215540004801203","article-title":"Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors","volume":"48","author":"Rajaniemi","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"14","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1158\/0008-5472.CAN-13-1110","article-title":"Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII","volume":"73","author":"Zeidler","year":"2013","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Williams","year":"2012","journal-title":"J Med Chem"},{"key":"16","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.18632\/oncotarget.2882","article-title":"Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells","volume":"6","author":"Riganti","year":"2015","journal-title":"Oncotarget"},{"key":"17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Bates","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1517\/17425255.2011.562892","article-title":"Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?","volume":"7","author":"Sarkadi","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","article-title":"Communication between multiple drug binding sites on P-glycoprotein","volume":"58","author":"Callaghan","year":"2000","journal-title":"Mol Pharmacol"},{"key":"20","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1021\/jm901888x","article-title":"Sulfonamide Linked Neoglycoconjugates - A New Class of Inhibitors for Cancer-Associated Carbonic Anhydrases","volume":"53","author":"Poulsen","year":"2010","journal-title":"J Med Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/jm5012935","article-title":"Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates","volume":"57","author":"Poulsen","year":"2014","journal-title":"J Med Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Bates","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"23","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/bjc.2012.32","article-title":"Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification","volume":"106","author":"Blackwell","year":"2012","journal-title":"Br J Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/ijc.20959","article-title":"Na+\/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin","volume":"115","author":"Bosia","year":"2005","journal-title":"Int J Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1021\/bi0619526","article-title":"P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells","volume":"46","author":"Seelig","year":"2007","journal-title":"Biochemistry"},{"key":"26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3727\/000000003108748603","article-title":"Development of a syngeneic in vivo tumor model and its use in evaluating a novel p-glycoprotein modulator, pgp-4008","volume":"14","author":"Smith","year":"2003","journal-title":"Oncol Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canlet.2015.02.008","article-title":"Two repeated low doses of doxorubicin are more effective than one single high dose against tumors overexpressing P-glycoprotein","volume":"360","author":"Kopecka","year":"2015","journal-title":"Cancer Lett"},{"key":"28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ar.a.20001","article-title":"Expression of hypoxia-inducible, membrane-bound carbonic anhydrase isozyme XII in mouse tissues","volume":"277A","author":"Parkkila","year":"2004","journal-title":"Anat Rec"},{"key":"30","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1186\/1471-2199-8-22","article-title":"A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system","volume":"8","author":"Parkkila","year":"2007","journal-title":"BMC Molecular Biology"},{"key":"31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1245\/s10434-015-4405-7","article-title":"Landscape of neoadjuvant therapy for breast cancer","volume":"22","author":"Goetz","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"32","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1021\/jm900914e","article-title":"S-Glycosyl primary sulfonamides - A new structural class for selective inhibition of cancer-associated carbonic anhydrases","volume":"52","author":"Poulsen","year":"2009","journal-title":"J Med Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1021\/jm101525j","article-title":"Design, Synthesis, and Biological Evaluation of Novel Carbohydrate-Based Sulfamates as Carbonic Anhydrase Inhibitors","volume":"54","author":"Poulsen","year":"2011","journal-title":"J Med Chem"},{"key":"34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/0008-5472.516.65.2","article-title":"Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux","volume":"65","author":"Bosia","year":"2005","journal-title":"Cancer Res"},{"key":"35","first-page":"323","article-title":"Establishment and characterization of multidrug-resistant human osteosarcoma cell lines","volume":"13","author":"Baldini","year":"1993","journal-title":"Anticancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1186\/1476-4598-8-108","article-title":"iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells","volume":"8","author":"Riganti","year":"2009","journal-title":"Mol Cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1541-7786.MCR-08-0251","article-title":"RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells","volume":"6","author":"Bosia","year":"2008","journal-title":"Mol Cancer Res"},{"key":"38","first-page":"djv046","article-title":"The Role of C\/EBP-\u03b2 LIP in Multidrug Resistance","volume":"107","author":"Rubinstein","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/mp2001389","article-title":"Liposome-encapsulated doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells","volume":"8","author":"Bosia","year":"2011","journal-title":"Mol Pharm"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T06:08:14Z","timestamp":1657606094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":39,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016,12,27]]}},"alternative-id":["13040","27811376"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13040","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}